Cargando…

Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy

Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies d...

Descripción completa

Detalles Bibliográficos
Autores principales: Warner, Richard B., Najy, Abdo J., Jung, Young Suk, Fridman, Rafael, Kim, Seongho, Kim, Hyeong-Reh Choi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005868/
https://www.ncbi.nlm.nih.gov/pubmed/32034211
http://dx.doi.org/10.1038/s41598-020-58964-x
_version_ 1783495026741870592
author Warner, Richard B.
Najy, Abdo J.
Jung, Young Suk
Fridman, Rafael
Kim, Seongho
Kim, Hyeong-Reh Choi
author_facet Warner, Richard B.
Najy, Abdo J.
Jung, Young Suk
Fridman, Rafael
Kim, Seongho
Kim, Hyeong-Reh Choi
author_sort Warner, Richard B.
collection PubMed
description Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies demonstrated increased expression of TIMP-1 and its association with poor prognosis in cancer. Non-MMP-inhibitory and oncogenic functions of TIMP-1 are mediated by induction of intracellular signaling via its cell surface receptor CD63, a tetraspanin. The present study investigates the structure-function relationship of TIMP-1 for its interaction with CD63, which may eventually help design a novel approach for targeting TIMP-1’s pro-oncogenic activity without interfering its tumor suppressive MMP-inhibitory function. Importantly, our analysis includes TIMP-1/CD63 interactions at the cell surface of live cells. Here, we demonstrate that the 9 C-terminal amino acid residues of TIMP-1 and the large extracellular loop of CD63 are required for their interaction. Considering that the N-terminal half of TIMP-1 is sufficient for TIMP-1’s MMP-inhibitory activity, we propose that those C-terminal amino acid residues are a potentially targetable motif of TIMP-1 oncogenic activity. As a proof of concept, we present the potential for the development of neutralizing antibodies against the C-terminal motif of TIMP-1 for disruption of TIMP-1 interaction with CD63 and the subsequent signal transduction.
format Online
Article
Text
id pubmed-7005868
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70058682020-02-18 Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy Warner, Richard B. Najy, Abdo J. Jung, Young Suk Fridman, Rafael Kim, Seongho Kim, Hyeong-Reh Choi Sci Rep Article Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies demonstrated increased expression of TIMP-1 and its association with poor prognosis in cancer. Non-MMP-inhibitory and oncogenic functions of TIMP-1 are mediated by induction of intracellular signaling via its cell surface receptor CD63, a tetraspanin. The present study investigates the structure-function relationship of TIMP-1 for its interaction with CD63, which may eventually help design a novel approach for targeting TIMP-1’s pro-oncogenic activity without interfering its tumor suppressive MMP-inhibitory function. Importantly, our analysis includes TIMP-1/CD63 interactions at the cell surface of live cells. Here, we demonstrate that the 9 C-terminal amino acid residues of TIMP-1 and the large extracellular loop of CD63 are required for their interaction. Considering that the N-terminal half of TIMP-1 is sufficient for TIMP-1’s MMP-inhibitory activity, we propose that those C-terminal amino acid residues are a potentially targetable motif of TIMP-1 oncogenic activity. As a proof of concept, we present the potential for the development of neutralizing antibodies against the C-terminal motif of TIMP-1 for disruption of TIMP-1 interaction with CD63 and the subsequent signal transduction. Nature Publishing Group UK 2020-02-07 /pmc/articles/PMC7005868/ /pubmed/32034211 http://dx.doi.org/10.1038/s41598-020-58964-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Warner, Richard B.
Najy, Abdo J.
Jung, Young Suk
Fridman, Rafael
Kim, Seongho
Kim, Hyeong-Reh Choi
Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
title Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
title_full Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
title_fullStr Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
title_full_unstemmed Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
title_short Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
title_sort establishment of structure-function relationship of tissue inhibitor of metalloproteinase-1 for its interaction with cd63: implication for cancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005868/
https://www.ncbi.nlm.nih.gov/pubmed/32034211
http://dx.doi.org/10.1038/s41598-020-58964-x
work_keys_str_mv AT warnerrichardb establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy
AT najyabdoj establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy
AT jungyoungsuk establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy
AT fridmanrafael establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy
AT kimseongho establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy
AT kimhyeongrehchoi establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy